Injuries, Doping, and Sports Medicine at the Olympics with UCLA Health Sciences Experts
Article ID: 613500
Released: 7-Feb-2014 10:00 AM EST
Source Newsroom: University of California, Los Angeles (UCLA), Health Sciences
Newswise — The following sports medicine experts are available from UCLA Health Sciences to discuss doping, injuries, and other sports medicine topics related to the 2014 Winter Olympics in Sochi, Russia.
Anthony Butch is director of the UCLA Olympic Analytical Laboratory, the largest World Anti-Doping Agency–accredited sports drug–testing facility in the world and one of the leading research institutions in the field of athletic doping. Butch oversees more than 40 scientists who analyze approximately 45,000 specimens each year for traces of banned substances intended to give athletes an unfair competitive edge. Founded in 1982 to perform testing of athletes competing in the 1984 Olympic Games, the UCLA facility was the first U.S. laboratory accredited by the International Olympic Committee.
Dr. Eric Vilain, professor of human genetics, pediatrics and urology and chief of medical genetics at the David Geffen School of Medicine at UCLA, studies the genetics of sexual development, including disorders of sex development. Vilain has been quoted frequently in the media on the subject of athletes whose gender is ambiguous and on the International Olympic Committee's efforts to address this issue. He is a member of the IOC panel on hyper-androgenism (the high production of androgen, a male sex hormone) in female athletes.